VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare if the combination of valsartan 320 mg/lisinopril 20
mg versus the monotherapies of lisinopril 40 mg or valsartan 320 mg will result in a greater
decrease of urinary albumin excretion measured as urinary albumin/creatinine ratio (UACR) in
the first morning urine of hypertensive subjects with previously diagnosed microalbuminuria
(MAU).